TRANSLATIONAL GENOMICS RESEARCH INSTITUTE: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (EIN 75-3065445)
Tax period
2019-10-01 to 2020-09-30
Filed
2021-08-12
IRS object ID
202102249349301895
Schema version
2019v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-08-12T19:59:56-05:00ReturnTs
Tax Period End2020-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1101 E WASHINGTON ST STE 910AddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN753065445EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% KEVIN GROFFInCareOfNm
Business Name ControlTRANBusinessNameControlTxt
Phone6023438400PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1445 N 5TH STREET Suite 600AddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonMANUEL ESTRADAPersonNm
Person TitleCFOPersonTitleTxt
Phone6023438400PhoneNum
Signature2021-08-09SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonPATRICK SHIELDSPreparerPersonNm
PTINP01508556PTIN
Phone6023223000PhoneNum
Preparation2021-08-12PreparationDt
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJEFFREY M TRENT PHDPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1445 N 5TH STREETAddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$83,920,797GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.TGEN.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2002FormationYr
Legal Domicile StateAZLegalDomicileStateCd
Activity Or MissionSEE SCHEDULE OActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent10VotingMembersIndependentCnt
Total Employee419TotalEmployeeCnt
Total Volunteers62TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$62,343,578PYContributionsGrantsAmt
CY Contributions Grants$54,124,639CYContributionsGrantsAmt
PY Program Service Revenue$17,942,426PYProgramServiceRevenueAmt
CY Program Service Revenue$23,939,255CYProgramServiceRevenueAmt
PY Investment Income$479,922PYInvestmentIncomeAmt
CY Investment Income$406,035CYInvestmentIncomeAmt
PY Other Revenue-$3,337,378PYOtherRevenueAmt
CY Other Revenue-$4,320,536CYOtherRevenueAmt
PY Total Revenue$77,428,548PYTotalRevenueAmt
CY Total Revenue$74,149,393CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$30,375,329PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$37,899,661CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$34,497,493PYOtherExpensesAmt
CY Other Expenses$40,903,399CYOtherExpensesAmt
PY Total Expenses$64,872,822PYTotalExpensesAmt
CY Total Expenses$78,803,060CYTotalExpensesAmt
PY Revenues Less Expenses$12,555,726PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$4,653,667CYRevenuesLessExpensesAmt
Total Assets BOY$140,891,715TotalAssetsBOYAmt
Total Assets EOY$140,363,431TotalAssetsEOYAmt
Total Liabilities BOY$58,482,929TotalLiabilitiesBOYAmt
Total Liabilities EOY$62,473,382TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$82,408,786NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$77,890,049NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$18,388,607ExpenseAmt
Grant$0GrantAmt
Revenue$10,645,477RevenueAmt
DescCLINICAL GENOMICS REFERENCE LABORATORY - SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$8,406,478ExpenseAmt
Grant$0GrantAmt
Revenue$7,460,949RevenueAmt
DescPATHOGEN AND MICROBIOME - SEE SCHEDULE ODesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$5,000,535ExpenseAmt
Grant$0GrantAmt
Revenue$3,202,871RevenueAmt
DescINTEGRATED CANCER - SEE SCHEDULE ODesc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$26,486,613TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$2,653,958TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$58,282,233TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingYes (true)CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntYes (true)BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (true)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document76IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee419EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member10IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersYes (true)MembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (true)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonKEVIN GROFFPersonNm
Phone6023438478PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1445 N 5TH STREET SUITE 600AddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ROBERT STONE
BD & VICE CHRM/COH CEO & PRES.1.059.0Yes (X)Yes (X)$0$3,717,559$507,612
JENNIFER PARKHURST
TREASURER/COH CFO1.059.0Yes (X)$0$1,131,123$350,199
JEFFREY M TRENT PHD
BOARD MEMBER/PRES/SCIENCE DIR.39.01.0Yes (X)Yes (X)$0$1,332,028$52,921
GREGORY SCHETINA
SECRETARY/COH GENERAL COUNSEL1.059.0Yes (X)$0$1,060,596$195,382
DANIEL VON HOFF
PHYSICIAN IN CHIEF40.00.0$875,090$0$21,764Yes (X)
CORNELIS VAN DEN BERG
FORMER TREASURER0.060.0$0$697,350$54,209Yes (X)
TERESA BURLESON
CHIEF OPERATING OFFICER39.01.0Yes (X)$534,670$0$117,669
SUNIL SHARMA
DEPUTY DIR OF CLINIC. SCIENCES40.00.0$549,285$0$21,450Yes (X)
MICHAEL BERENS
DEPUTY DIRECTOR OF RESEARCH40.00.0$488,370$0$30,518Yes (X)
NICHOLAS SCHORK
PROFESSOR40.00.0$383,895$0$19,559Yes (X)
JULIA BRIDGE
PROFESSOR40.00.0$388,575$0$13,155Yes (X)
THOMAS ROYCE
ASHION EXECUTIVE DIRECTOR40.00.0$373,827$0$21,510Yes (X)
STEPHANIE MCRAE
GENERAL COUNSEL/ASST SECRETARY40.00.0Yes (X)$328,707$0$16,464
MANUEL ESTRADA
CFO/ASSISTANT TREASURER39.01.0Yes (X)$319,895$0$20,250
TIMOTHY MCDANIEL
SR. VP OF EMERG. OPPORTUNITIES40.00.0$308,000$0$23,258Yes (X)
JAMES LOWEY
CHIEF INFORMATION OFFICER40.00.0Yes (X)$272,259$0$15,340
JANINE LOBELLO
ASHION CLINICAL LAB DIRECTOR40.00.0$264,789$0$14,783Yes (X)
KENDALL JENSEN
DEPUTY DIR. OF RESEARCH RES.40.00.0$252,861$0$20,326Yes (X)
JOHANNA DISTEFANO
PROFESSOR40.00.0$253,879$0$13,537Yes (X)
WILLIAM J POST
BOARD MEMBER/CHAIRMAN1.01.0Yes (X)Yes (X)$0$0$0
ROBERT BULLA
BOARD MEMBER1.00.0Yes (X)$0$0$0
BENNETT DORRANCE
BOARD MEMBER1.01.0Yes (X)$0$0$0
DAVID J GULLEN MD
BOARD MEMBER1.00.0Yes (X)$0$0$0
SHARON HARPER
BOARD MEMBER1.00.0Yes (X)$0$0$0
PAMELA KEHALY
BOARD MEMBER1.00.0Yes (X)$0$0$0
CINDY PARSEGHIAN
BOARD MEMBER1.00.0Yes (X)$0$0$0
TERRY PEETS
BOARD MEMBER1.00.0Yes (X)$0$0$0
MARILYN QUAYLE
BOARD MEMBER1.00.0Yes (X)$0$0$0
ANTHONY SCOTT
Board Member1.00.0Yes (X)$0$0$0
RICHARD SILVERMAN
BOARD MEMBER1.00.0Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,594,102TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$7,938,656TotReportableCompRltdOrgAmt
Total Other Compensation$1,529,906TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K64IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Girikon LLC
15433 N TATUM BLVD SUITE 105PHOENIXAZ85032CONSULTING SERVICES$249,876
BOOTH UDALL FULLER PLC
1255 W RIO SALADO PKWY SUITE 215TEMPEAZ85281LEGAL SERVICES$225,938
FIRSTSTRATEGIC
300 W CLARENDON AVE SUITE 460PHOENIXAZ85013CONSULTING SERVICES$216,000
TECH66 LLC
4557 E VIA LOS CABALLOSPHOENIXAZ85028CONSULTING SERVICES$157,842
ASG GROUP LLC
30 POVERTY ROADSOUTHBURYCT06488CONSULTING SERVICES$111,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Related Organizations$36,052,687RelatedOrganizationsAmt
Government Grants$8,467,201GovernmentGrantsAmt
All Other Contributions$9,604,751AllOtherContributionsAmt
Noncash Contributions$19,445NoncashContributionsAmt
Total Contributions$54,124,639TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescRESEARCH CONTRACTSDesc
Business541711BusinessCd
Total Revenue Column$23,939,255TotalRevenueColumnAmt
Related Or Exempt Func Income$23,939,255RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$23,939,255TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$139,512TotalRevenueColumnAmt
Exclusion$139,512ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$2,917,029RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$7,261,565RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real-$4,344,536RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$4,344,536TotalRevenueColumnAmt
Exclusion-$4,344,536ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$858,926SecuritiesAmt
Other$1,917,436OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$709,084SecuritiesAmt
Other$1,800,755OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$149,842SecuritiesAmt
Other$116,681OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$266,523TotalRevenueColumnAmt
Exclusion$266,523ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Fundraising Direct Expenses$0FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescALL OTHER REVENUEDesc
Business900099BusinessCd
Total Revenue Column$24,000TotalRevenueColumnAmt
Related Or Exempt Func Income$24,000RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$24,000OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$74,149,393TotalRevenueColumnAmt
Related Or Exempt Func Income$23,963,255RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$3,938,501ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,843,763TotalAmt
Program Services$2,187,063ProgramServicesAmt
Management And General$2,656,700ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$27,956,010TotalAmt
Program Services$18,185,934ProgramServicesAmt
Management And General$9,770,076ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$964,020TotalAmt
Program Services$597,856ProgramServicesAmt
Management And General$366,164ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,180,595TotalAmt
Program Services$1,343,468ProgramServicesAmt
Management And General$837,127ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,955,273TotalAmt
Program Services$938,605ProgramServicesAmt
Management And General$1,016,668ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$486,324TotalAmt
Program Services$3,026ProgramServicesAmt
Management And General$483,298ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$294,766TotalAmt
Program Services$10,010ProgramServicesAmt
Management And General$284,756ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$129,600TotalAmt
Program Services$0ProgramServicesAmt
Management And General$129,600ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$9,390,122TotalAmt
Program Services$7,616,665ProgramServicesAmt
Management And General$1,773,457ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$266,575TotalAmt
Program Services$26,971ProgramServicesAmt
Management And General$239,604ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$16,056,989TotalAmt
Program Services$15,249,502ProgramServicesAmt
Management And General$807,487ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,486,905TotalAmt
Program Services$1,748,198ProgramServicesAmt
Management And General$738,707ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$443,357TotalAmt
Program Services$333,387ProgramServicesAmt
Management And General$109,970ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$398,424TotalAmt
Program Services$206,403ProgramServicesAmt
Management And General$192,021ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$248,262TotalAmt
Program Services$143,058ProgramServicesAmt
Management And General$105,204ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$142,476TotalAmt
Program Services$38,861ProgramServicesAmt
Management And General$103,615ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$7,620,918TotalAmt
Program Services$7,270,173ProgramServicesAmt
Management And General$350,745ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$361,916TotalAmt
Program Services$65,326ProgramServicesAmt
Management And General$296,590ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
BAD DEBT EXPENSE$2,170,915$2,161,210$9,705$0
RECRUITMENT$202,069$111,053$91,016$0
DUES & SUBSCRIPTION$149,032$45,377$103,655$0
RELOCATION$31,227$87$31,140$0

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$23,522TotalAmt
Management And General$23,522ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$78,803,060TotalAmt
Program Services$58,282,233ProgramServicesAmt
Management And General$20,520,827ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$14,053,892BOYAmt
EOY$21,756,000EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$6,122,458BOYAmt
EOY$6,429,969EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$11,990,764BOYAmt
EOY$12,511,721EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,135,090BOYAmt
EOY$2,479,127EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$175,000BOYAmt
EOY$131,482EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$1,206,243BOYAmt
EOY$1,221,231EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,311,887BOYAmt
EOY$1,020,134EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$82,013,230LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$19,308,788LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$63,351,563BOYAmt
EOY$62,704,442EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$1,627,867BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$9,118,329BOYAmt
EOY$9,093,349EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$30,798,622BOYAmt
EOY$23,015,976EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$140,891,715BOYAmt
EOY$140,363,431EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$9,342,928BOYAmt
EOY$11,933,405EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$3,286,229BOYAmt
EOY$3,103,374EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$426,199BOYAmt
EOY$213,099EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$50,000BOYAmt
EOY$50,000EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$43,944,912BOYAmt
EOY$45,982,796EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$50,000BOYAmt
EOY$50,000EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,382,661BOYAmt
EOY$1,140,708EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$58,482,929BOYAmt
EOY$62,473,382EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$72,631,994BOYAmt
EOY$68,899,823EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$9,776,792BOYAmt
EOY$8,990,226EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$82,408,786BOYAmt
EOY$77,890,049EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$140,891,715BOYAmt
EOY$140,363,431EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$4,653,667ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$176,849NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense-$41,919InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$67,494,504CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$17,588,654CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,879,587CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$62,343,578CurrentTaxYearMinus1YearAmt
Current Tax Year$54,124,639CurrentTaxYearAmt
Total$233,430,962TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$67,494,504CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$17,588,654CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,879,587CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$62,343,578CurrentTaxYearMinus1YearAmt
Current Tax Year$54,124,639CurrentTaxYearAmt
Total$233,430,962TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$7,482,414SubstantialContributorsTotAmt
Public Support Total170$225,948,548PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$143,205CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$109,024CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$4,179,409CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,155,820CurrentTaxYearMinus1YearAmt
Current Tax Year$3,056,541CurrentTaxYearAmt
Total$10,643,999TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus2 Years$5,677,144CurrentTaxYearMinus2YearsAmt
Total$5,677,144TotalAmt
FieldValueIRS element (for citing)
Total Support$249,752,105TotalSupportAmt
Gross Receipts Rltd Activities$100,800,884GrossReceiptsRltdActivitiesAmt
Public Support CY1700.90469PublicSupportCY170Pct
Public Support PY1700.88910PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART IIFormAndLineReferenceDesc
ExplanationTHE AMOUNTS INCLUDED IN SCHEDULE A, PART II CORRESPOND TO THE FOLLOWING PERIODS: COLUMN (E) 2019 : 10/01/2019-09/30/2020 COLUMN (D) 2018 : 10/01/2018-09/30/2019 COLUMN (C) 2017 : 10/01/2017-09/30/2018 COLUMN (B) 2016 : 01/01/2017-09/30/2017 (SHORT PERIOD) COLUMN (A) 2015 : 01/01/2016-12/31/2016ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementfalsePaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Media Advertisements$0MediaAdvertisementsAmt
Mailings MembersfalseMailingsMembersInd
Mailings Members$0MailingsMembersAmt
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Publications Or Broadcast$0PublicationsOrBroadcastAmt
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Grants Other Organizations$0GrantsOtherOrganizationsAmt
Direct Contact LegislatorsfalseDirectContactLegislatorsInd
Direct Contact Legislators$0DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Rallies Demonstrations$0RalliesDemonstrationsAmt
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$129,600OtherActivitiesAmt
Total Lobbying Expenditures$129,600TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE C, PART II-B, LINE 1IFormAndLineReferenceDesc
ExplanationTHE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN) USES A THIRD PARTY COMMUNICATIONS AND PUBLIC AFFAIRS FIRM TO COORDINATE LOBBYING EFFORTS ON BEHALF OF TGEN THROUGH COMMUNICATIONS TO LOCAL GOVERNMENT, LEGISLATIVE AND FEDERAL OFFICIALS AND COMMUNITY LEADERS ON TGEN ACTIVITIES.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
Agent Trustee EtcfalseAgentTrusteeEtcInd
Incl Escrow Custodial Acct LiabYes (true)InclEscrowCustodialAcctLiabInd
Explanation ProvidedYes (X)ExplanationProvidedInd

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,186,285BeginningYearBalanceAmt
Contributions$378,481ContributionsAmt
Investment Earnings Or Losses$419,824InvestmentEarningsOrLossesAmt
Other Expenditures$287,763OtherExpendituresAmt
End Year Balance$6,696,827EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,088,052BeginningYearBalanceAmt
Contributions$1,373,720ContributionsAmt
Investment Earnings Or Losses$227,248InvestmentEarningsOrLossesAmt
Other Expenditures$502,735OtherExpendituresAmt
End Year Balance$6,186,285EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,355,690BeginningYearBalanceAmt
Contributions$75,833ContributionsAmt
Investment Earnings Or Losses$182,488InvestmentEarningsOrLossesAmt
Other Expenditures$525,959OtherExpendituresAmt
End Year Balance$5,088,052EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,258,044BeginningYearBalanceAmt
Contributions$46,076ContributionsAmt
Investment Earnings Or Losses$525,676InvestmentEarningsOrLossesAmt
Grants Or Scholarships$4,658GrantsOrScholarshipsAmt
Other Expenditures$469,448OtherExpendituresAmt
End Year Balance$5,355,690EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,384,983BeginningYearBalanceAmt
Investment Earnings Or Losses$374,012InvestmentEarningsOrLossesAmt
Other Expenditures$500,951OtherExpendituresAmt
End Year Balance$5,258,044EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.00000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.28410PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.71590TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (true)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (true)RelatedOrgListSchRInd

Land LandGrp

FieldValueIRS element (for citing)
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$47,449,788OtherCostOrOtherBasisAmt
Depreciation$3,063,432DepreciationAmt
Book Value$44,386,356BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,256,831OtherCostOrOtherBasisAmt
Depreciation$1,610,221DepreciationAmt
Book Value$1,646,610BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$25,584,495OtherCostOrOtherBasisAmt
Depreciation$12,870,676DepreciationAmt
Book Value$12,713,819BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,722,116OtherCostOrOtherBasisAmt
Depreciation$1,764,459DepreciationAmt
Book Value$3,957,657BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$62,704,442TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (3 entries)

DescDescBook ValueBookValueAmt
DUE FROM CITY OF HOPE$11,500,707
DUE FROM TGEN FOUNDATION$10,374,561
INVESTMENT IN 457(B) PLAN$1,140,708
FieldValueIRS element (for citing)
Total Book Value Other Assets$23,015,976TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDUE TO EMPLOYEE 457(B) PLANDesc
Amt$1,140,708Amt
FieldValueIRS element (for citing)
Total Liability$1,140,708TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$74,149,393TotalRevEtcAuditedFinclStmtAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported$0RevenueNotReportedAmt
Revenue Subtotal$74,149,393RevenueSubtotalAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$74,149,393TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$78,803,060TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$78,803,060ExpensesSubtotalAmt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$78,803,060TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART IV, LINE 2BCERTAIN TENANT RENTAL OVER PAYMENTS WERE TRANSFERRED IN THE OCTOBER 2017 BUILDING TRANSACTION WITH THE CITY OF PHOENIX. PER THE TENANT LEASES, AMOUNTS WILL BE PAID IN CASH AND CREDITS OVER A FOUR YEAR PERIOD ENDING IN SEPTEMBER 2021.
SCHEDULE D, PART V, LINE 4TGEN'S POLICY FOR APPROPRIATING THE DISTRIBUTION OF ITS SUMMER INTERNSHIP PROGRAM ENDOWMENT HAS BEEN DESIGNED TO SUPPORT A SPECIFIC NUMBER OF SUMMER INTERNS EACH YEAR FOR 25 YEARS. THE INSTITUTE CONSIDERED THE LONG-TERM EXPECTED RETURN ON ITS ENDOWMENT. TGEN FOUNDATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF THE GIFT DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS DONATED TO THE PERMANENT ENDOWMENT, AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT. TGEN FOUNDATION HAS A TEMPORARILY RESTRICTED ASSET WHICH HAS BEEN DESIGNED TO SUPPORT A SUMMER INTERN EACH YEAR AT TGEN. TGEN FOUNDATION'S POLICY FOR APPROPRIATING THE DISTRIBUTION OF ITS SUMMER INTERNSHIP PROGRAM ENDOWMENT HAS BEEN DESIGNED TO SUPPORT A GRANT TO TGEN FOR AN INTERN EACH YEAR FOR 20 YEARS. THE FOUNDATION CONSIDERED THE LONG-TERM EXPECTED RETURN ON ITS ENDOWMENT. TGEN FOUNDATION HAS A RESTRICTED ASSET FOR THE ESTABLISHMENT OF AN ENDOWED CHAIR IN BRAIN CANCER RESEARCH. TGEN FOUNDATION ALSO HAS A RESTRICTED ASSET WHICH ALLOWS THEM TO USE ANY INVESTMENT INCOME FOR OPERATING EXPENSES.
SCHEDULE D, PART XIIITGEN AND THE FOUNDATION ARE EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE. TGEN AND THE FOUNDATION ARE EXEMPT FROM ARIZONA CORPORATE INCOME TAX UNDER SECTION 43-1201(A) OF THE ARIZONA REVISED STATUTES (A.R.S.) ACCORDINGLY, NO PROVISION FOR INCOME TAX IS INCLUDED IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS. TGEN AND THE FOUNDATION HAVE NO SIGNIFICANT UNCERTAIN TAX POSITIONS OR TAX LIABILITY FOR TAX BENEFITS, INTEREST, OR PENALTIES ACCRUED AT SEPTEMBER 30, 2020.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)Program servicesRESEARCH SERVICES$149,224
North AmericaProgram servicesRESEARCH SERVICES$28,362
South AsiaProgram servicesRESEARCH SERVICES$9,600
Middle East and North AfricaProgram servicesRESEARCH SERVICES$2,431
East Asia and the PacificProgram servicesRESEARCH SERVICES$395
FieldValueIRS element (for citing)
Subtotal Spent$190,012SubtotalSpentAmt
Total Spent$190,012TotalSpentAmt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE F, PART I, LINE 3, COLUMN (F)FormAndLineReferenceDesc
ExplanationTHE AMOUNTS REPORTED IN COLUMN (F) ARE DETERMINED BASED ON THE ACCRUAL METHOD OF ACCOUNTING.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JEFFREY M TRENT PHD
BOARD MEMBER/PRES/SCIENCE DIR.$0$815,491$0$427,500$0$89,037$0$22,684$0$30,237$0$1,384,949$0$0
ROBERT STONE
BD & VICE CHRM/COH CEO & PRES.$0$1,471,214$0$2,116,992$0$129,353$0$468,184$0$39,428$0$4,225,171$0$397,500
TERESA BURLESON
CHIEF OPERATING OFFICER$482,828$0$50,000$0$1,842$0$107,327$0$10,342$0$652,339$0$0$0
MANUEL ESTRADA
CFO/ASSISTANT TREASURER$275,385$0$43,100$0$1,410$0$8,409$0$11,841$0$340,145$0$0$0
JAMES LOWEY
CHIEF INFORMATION OFFICER$234,669$0$35,809$0$1,781$0$10,971$0$4,369$0$287,599$0$0$0
STEPHANIE MCRAE
GENERAL COUNSEL/ASST SECRETARY$270,131$0$56,734$0$1,842$0$2,606$0$13,858$0$345,171$0$0$0
JENNIFER PARKHURST
TREASURER/COH CFO$0$727,272$0$396,984$0$6,867$0$304,055$0$46,144$0$1,481,322$0$0
GREGORY SCHETINA
SECRETARY/COH GENERAL COUNSEL$0$524,386$0$490,550$0$45,660$0$145,280$0$50,102$0$1,255,978$0$118,210
MICHAEL BERENS
DEPUTY DIRECTOR OF RESEARCH$344,579$0$120,000$0$23,791$0$18,521$0$11,997$0$518,888$0$97,222$0
TIMOTHY MCDANIEL
SR. VP OF EMERG. OPPORTUNITIES$265,165$0$41,593$0$1,242$0$10,210$0$13,048$0$331,258$0$0$0
SUNIL SHARMA
DEPUTY DIR OF CLINIC. SCIENCES$498,443$0$30,000$0$20,842$0$8,616$0$12,834$0$570,735$0$0$0
DANIEL VON HOFF
PHYSICIAN IN CHIEF$720,164$0$150,000$0$4,926$0$9,736$0$12,028$0$896,854$0$108,333$0
THOMAS ROYCE
ASHION EXECUTIVE DIRECTOR$283,287$0$90,000$0$540$0$11,180$0$10,330$0$395,337$0$0$0
JANINE LOBELLO
ASHION CLINICAL LAB DIRECTOR$264,249$0$0$0$540$0$10,711$0$4,072$0$279,572$0$0$0
JOHANNA DISTEFANO
PROFESSOR$241,856$0$10,203$0$1,820$0$9,147$0$4,390$0$267,416$0$0$0
KENDALL JENSEN
DEPUTY DIR. OF RESEARCH RES.$242,021$0$9,626$0$1,214$0$6,027$0$14,299$0$273,187$0$0$0
JULIA BRIDGE
PROFESSOR$365,559$0$20,000$0$3,016$0$4,159$0$8,996$0$401,730$0$0$0
NICHOLAS SCHORK
PROFESSOR$359,603$0$21,970$0$2,322$0$11,132$0$8,427$0$403,454$0$0$0
CORNELIS VAN DEN BERG
FORMER TREASURER$0$466,406$0$186,511$0$44,433$0$28,213$0$25,996$0$751,559$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE J, PART I, LINE 4BCERTAIN CITY OF HOPE'S EXECUTIVES PARTICIPATE IN THE CITY OF HOPE'S NON-QUALIFIED 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICES AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B (III). PRIOR TO VESTING, THE ANNUAL AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN C. PURSUANT TO THE PLAN DOCUMENTS, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL, AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. DURING THE CALENDAR YEAR ENDING DECEMBER 31, 2019, THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: ROBERT STONE $34,762 GREGORY SCHETINA $9,352 THESE AMOUNTS HAVE BEEN INCLUDED IN THE PARTICIPANTS INCOME ON SCHEDULE J, PART II, COLUMN B (III).
SCHEDULE J, PART I, LINE 7SOME OF TGEN'S OFFICERS AND KEY EMPLOYEES LISTED IN PART VII WERE PAID BONUSES WHICH WERE BASED ON ACCOMPLISHMENTS OF SPECIFIC MILESTONES AND/OR PERFORMANCE METRICS, AS APPROVED BY THE TGEN BOARD OF DIRECTORS.
SCHEDULE J, PART IISOME OF TGEN'S OFFICERS AND KEY EMPLOYEES LISTED IN PART VII HAVE RETENTION AGREEMENTS THROUGH 2019, 2020 AND 2021. AMOUNTS ACCRUED BY TGEN DURING CALENDAR YEAR 2019 UNDER THESE AGREEMENTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN (C) AS DEFERRED COMPENSATION.

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (2 entries)

Relationship With OrgRelationshipWithOrgTxtLoan PurposeLoanPurposeTxtLoan To OrganizationLoanToOrganizationIndOriginal PrincipalOriginalPrincipalAmtBalance DueBalanceDueAmtDefaultDefaultIndBoard Or Committee ApprovalBoardOrCommitteeApprovalIndWritten AgreementWrittenAgreementIndLoan From OrganizationLoanFromOrganizationInd
BENNETT DORRANCE
BOARD MEMBERSEE PART VYes (X)$50,000$50,000falseYes (true)Yes (true)
KENDALL JENSEN
EMPLOYEERELOCATION ASSIST.$250,000$125,000falseYes (true)Yes (true)Yes (X)
FieldValueIRS element (for citing)
Total Balance Due$175,000TotalBalanceDueAmt

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonTECH66 LLC WILLIAM BURLESONPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionSPOUSE OF OFFICERRelationshipDescriptionTxt
Transaction$200,852TransactionAmt
TransactionCONSULTING FEESTransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE L, PART II, LINE 1, COLUMN (C)FormAndLineReferenceDesc
ExplanationCAPITALIZE NEW ENTITY FORMED FOR BIOMARKER RESEARCH.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (14 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1 and PART III, LINE 1THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN) IS A NONPROFIT BIOMEDICAL RESEARCH INSTITUTE FOCUSED ON DEVELOPING EARLIER AND SMARTER TREATMENTS BY EMPLOYING INNOVATIVE ADVANCES ARISING FROM THE HUMAN GENOME PROJECT AND APPLYING THEM TO THE DEVELOPMENT OF DIAGNOSTICS, PROGNOSTICS AND THERAPIES FOR CANCER, NEUROLOGICAL DISORDERS, DIABETES AND OTHER COMPLEX DISEASES. FORM 990, PART III, LINE 4A TGEN'S CLINICAL GENOMIC SEQUENCING IS PROVIDED THROUGH ASHION, A TGEN SPECIALTY LAB, ESTABLISHED IN 2011, WHICH IS A CAP ACCREDITED AND CLIA-CERTIFIED TESTING LABORATORY COMMITTED TO ACCELERATING THE ADOPTION OF PRECISION MEDICINE IN THE CARE STREAM. THE LABORATORY USES NEXT-GENERATION SEQUENCING TECHNOLOGY AND PROPRIETARY INFORMATICS SYSTEMS FOR ANALYSIS AND DRUG MATCHING. TUMOR/NORMAL SEQUENCING IS PERFORMED FOR ALL OF TGEN'S PRECISION MEDICINE ONCOLOGY TRIALS. THE LABORATORY ALSO PROVIDES GENOMIC SEQUENCING SERVICES FOR TGEN'S CENTER FOR RARE CHILDHOOD DISORDERS. THE TEST MENU INCLUDES CLIA-CERTIFIED EXOME AND RNA SEQUENCING.
FORM 990, PART III, LINE 4BTHE PATHOGEN AND MICROBIOME DIVISION IS FOCUSED ON DEVELOPING AND TRANSLATING MICROBIAL GENOMIC DISCOVERIES INTO APPLICATION TO ADVANCE HUMAN HEALTH IN THE AREAS OF CLINICAL MEDICINE, PUBLIC HEALTH AND BIODEFENSE. THE DIVISION SEEKS TO ADVANCE OUR UNDERSTANDING OF MULTI-DRUG RESISTANT INFECTIONS, DEVELOP NOVEL GENOTYPING TECHNIQUES FOR GENOMIC EPIDEMIOLOGY AND MICROBIAL FORENSICS, FUNGAL EPIDEMIOLOGY AND PHYLOGENETICS, UNDERSTAND THE RELATIONSHIP OF MICROBES TO HUMAN HEALTH AND DISEASE, AND THROUGH THE TGEN NORTH CLIA LAB OFFER PCR AND SEROLOGY TESTING FOR SARS-COV-2. A MAJOR EMPHASIS IS ON ADAPTING AND ADVANCING NEXT-GENERATION SEQUENCING TOOLS FOR INFECTIOUS DISEASE RESEARCH AND HEALTHCARE SUCH AS DIAGNOSTIC TESTS TO CHARACTERIZE AND TRACK HOSPITAL ACQUIRED INFECTIONS, WITH AN EMPHASIS ON ANTIBIOTIC RESISTANCE, ALLOWING PHYSICIANS TO PROVIDE PERSONALIZED THERAPY AND CONTAIN OUTBREAKS. ASSAYS HAVE BEEN TAILORED TO MANY DISEASES, ORGANISMS AND SAMPLE TYPES, INCLUDING MRSA, TUBERCULOSIS, KLEB, E COLI AND STAPHYLOCOCCUS. THE DIVISION WORKS CLOSELY WITH ITS SISTER INSTITUTE AT NORTHERN ARIZONA UNIVERSITY, THE PATHOGEN AND MICROBIOME INSTITUTE, AS WELL AS WITH A NUMBER OF OTHER COLLABORATORS LOCALLY, NATIONALLY AND GLOBALLY. THE DIVISION HAS BEEN INSTRUMENTAL IN SOLVING NUMEROUS DISEASE OUTBREAKS AROUND THE WORLD, HAS GENERATED MULTIPLE INVENTIONS AND HAS LICENSED OUT INTELLECTUAL PROPERTY TO GOVERNMENTS AND BIOTECH COMPANIES.
FORM 990, PART III, LINE 4CTHE DIVISION OF INTEGRATED CANCER GENOMICS IS UTILIZING STATE-OF-THE-ART MOLECULAR TECHNOLOGIES TO UNCOVER THE MULTIPLE DIMENSIONS OF MOLECULAR CHANGES THAT OCCUR IN CANCER, AND INTEGRATE THESE DATASETS TO CAPTURE A HIGH-RESOLUTION IMAGE OF THE TUMOR MOLECULAR LANDSCAPE. AMONG ICG FACULTY, THE DIVISION BOASTS AN AMAZING ARRAY OF COMPETENCIES INCLUDING GENOMIC PROFILING USING VARIOUS TECHNOLOGIES THAT INCLUDE NEXT-GENERATION SEQUENCING INCLUDING SINGLE-CELL, EPIGENETICS, NEOANTIGEN ANALYSIS, CANCER CELL BIOLOGY AND BIOINFORMATICS. ACROSS THE VARIOUS LABORATORIES, WE STUDY A MULTITUDE OF ADULT AND PEDIATRIC CANCERS, TRYING TO UNDERSTAND THE EVENTS THAT DRIVE CANCER PROGRESSION FROM PRIMARY TO ADVANCED METASTATIC DISEASE IN ADDITION TO UNDERSTANDING WHY AND HOW CANCER AFFECTS INDIVIDUALS FROM DIFFERENT ETHNICITIES AND ANCESTRAL BACKGROUNDS. ICG FACULTY ALSO ARE INVOLVED IN APPLYING HIGH-RESOLUTION GENOMIC TECHNOLOGIES TO PATIENT SAMPLES IN REAL TIME, DURING CLINICAL MANAGEMENT, TO ASSIST ONCOLOGISTS IN MAKING THERAPEUTIC RECOMMENDATIONS FOR CANCER PATIENTS. ICG IS DIRECTLY AIMING ITS EFFORTS TO DRIVE EARLIER DIAGNOSTICS AND SMARTER TREATMENTS TOWARDS PATIENTS.
FORM 990, PART III, LINE 4DRESEARCH PROGRESSED MARKEDLY IN 2020, RESULTING IN SIGNIFICANT RESULTS ACROSS A NUMBER OF BIOMEDICAL INVESTIGATIONS; FROM ALZHEIMER'S DISEASE TO CHILDREN'S BRAIN CANCER, COMPARATIVE ONCOLOGY AND DIABETES. VALIDATION OF TECHNOLOGY SUPPORTING THE MANY POTENTIAL FACETS OF TGEN'S CENTER FOR NONINVASIVE DIAGNOSTICS CREATED NEW OPPORTUNITIES AND NEW PATHWAYS FOR DIAGNOSING DISEASE. TGEN'S CAPABILITIES AND STRENGTH IN GENOMICS ALSO CAME TO THE FORE WHEN THE THREAT POSED BY SARS-COV-2 BECAME AN INTERNATIONAL PUBLIC THREAT. WITHIN DAYS OF HEARING OF THE POTENTIALLY DEADLY SARS-COV-2, TGEN NORTH SCIENTISTS BEGAN DEVELOPING A GENOMIC-BASED CLINICAL TEST TO CONFIRM INFECTION. FIVE WEEKS LATER, THE SCIENTISTS AT TGEN NORTH RECEIVED FDA EMERGENCY-USE AUTHORIZATION FOR A PCR-BASED GENETIC TEST FOR THE SARS-COV-2, WHILE SIMULTANEOUSLY STANDING UP AND RECEIVING STATE CERTIFICATION FOR ITS CLIA LABORATORY, A STEP NECESSARY TO RETURN TESTING RESULTS TO PATIENTS AND THEIR PHYSICIANS. THIS IS A TESTAMENT TO THE FORESIGHT OF TGEN NORTH LEADERSHIP WHO IN 2018 PUT TOGETHER TGEN'S ONE HEALTH COLLABORATIVE, AN INITIATIVE FOR PROTECTING PUBLIC HEALTH AND THE ENVIRONMENT, WORKING WITH LOCAL, STATE, FEDERAL AND INTERNATIONAL PUBLIC HEALTH OFFICIALS AND OTHERS TO TRACK THE CAUSE AND SOURCE OF DISEASE OUTBREAKS, ANTIBIOTIC RESISTANCE, HOSPITAL-ACQUIRED INFECTIONS, MICROBIAL EVOLUTION, PATHOGEN DISPERSAL, AND EMERGING INFECTIONS. WHILE SARS-COV-2 MAY HAVE SHAPED HOW WE WORKED AND LIVED FOR MUCH OF THE YEAR, IT DID NOT IMPEDE THE PROGRESS OF OUR FACULTY, NOR OUR COLLEAGUES AT CITY OF HOPE AND BEYOND. WHILE OUR WORK TOWARD SAFEGUARDING OUR COMMUNITIES AGAINST SARS-COV-2 BECAME PARAMOUNT, EFFORTS AROUND OUR CORE MISSION - HELPING PATIENTS SUFFERING FROM CANCER, NEUROLOGICAL DISEASES, DIABETES AND RARE CHILDHOOD DISORDERS - NEVER WANED. TGEN'S PARTNERSHIPS HAVE RESULTED IN VARIOUS MULTI-YEAR, MULTI-MILLION DOLLAR EFFORTS FUNDED BY THE NATIONAL INSTITUTES OF HEALTH CENTERED ON: CHLOROTOXIN-PREDICTED CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATMENT IN GLIOBLASTOMA, A SCALABLE PLATFORM FOR HIGHLY-MULTIPLEXED ANALYSIS OF ANTIBODY REACTIVITY FROM 1UL OF BLOOD, AND TREATMENT MONITORING IN EARLY AND LOCALLY ADVANCED BREAST CANCER USING CIRCULATING TUMOR DNA ANALYSIS. ADDITIONALLY, TGEN INVESTIGATORS WERE AWARDED GRANTS IN MULTIPLE FIELDS, INCLUDING NEUROGENOMICS, CANCER THERAPEUTICS AND TREATMENTS, AND DISEASE DETECTION AND MONITORING. TGEN ADVANCED A SERIES OF INNOVATIVE RESEARCH INITIATIVES THAT YIELDED NUMEROUS SCIENTIFIC DISCOVERIES (MANY WITH POTENTIAL CLINICAL APPLICATION), ESTABLISHED NATIONAL AND INTERNATIONAL COLLABORATIONS, AND LED NEW AND EXCITING CLINICAL TRIALS WITH PROMISING RESULTS IN THE AREAS OF PATHOGENIC DISEASE, CANCER DIAGNOSIS AND MONITORING, NEUROGENOMICS, AND CANINE CANCER. SPECIFICALLY, TGEN INVESTIGATORS ARE SEQUENCING SAMPLES FROM SARS-COV-2 PATIENTS TO ANALYZE THE VIRUS' GENETIC CODES AND TRACK ITS DIFFERENT STRAINS, IDENTIFYING THAT CERTAIN GENETIC ALTERATIONS IN KIDNEY CANCER TUMORS PREDICT WHICH PATIENTS WILL FAIL TO RESPOND TO THE LATEST CANCER DRUGS WHICH WORK BY BOOSTING THE PATIENT'S IMMUNE SYSTEM, DETECTING A PREDATOR-PREY RELATIONSHIP BETWEEN CIRCULATING IMMUNE CELL DYNAMICS AND TUMOR RESPONSE TO IMMUNOTHERAPY, USING ORGANOIDS, ORGAN-LIKE LABORATORY CULTURES DERIVED FROM PATIENT TUMORS, TO PROVIDE A NEW LEVEL OF ACCURACY IN PRESCRIBING ANTI-CANCER TREATMENTS, AND DETECTING UNIQUE LUNG CELLS THROUGH ONE OF THE FIRST COMPREHENSIVE LOOKS AT THE CELLS USING A TECHNOLOGY CALLED SINGLE-CELL RNA SEQUENCING THAT MAY DRIVE IDIOPATHIC PULMONARY FIBROSIS, A DEADLY LUNG DISEASE THAT AFFECTS HUNDREDS OF THOUSANDS OF AMERICANS AND FOR WHICH THERE IS NO CURE. TGEN INVESTIGATORS PUBLISHED THEIR RESEARCH RESULTS EXTENSIVELY IN SCHOLARLY PEER-REVIEWED ACADEMIC JOURNALS AND PRESENTED VIRTUALLY AT LEADING NATIONAL AND INTERNATIONAL CONFERENCES; INCLUDING PUBLICATION IN LEADING SCIENTIFIC JOURNALS SUCH AS AMERICAN JOURNAL OF HUMAN GENETICS, CELL, NATURE COMMUNICATIONS, JOURNAL OF NEUROSCIENCE, CLINICAL CANCER RESEARCH, JAMA NEUROLOGY, NEUROLOGY, NEW ENGLAND JOURNAL OF MEDICINE, SCIENCE TRANSLATIONAL MEDICINE, AND PRESENTATIONS AT LEADING CONFERENCES SUCH AS THE SU2C SCIENTIFIC SUMMIT. TGEN INVESTIGATORS FURTHER SERVE AS RESOURCES TO MEDICAL AND SCIENTIFIC RESEARCH CENTERS THROUGHOUT THE COUNTRY IN THEIR AREAS OF RESEARCH. IN EDUCATION AND OUTREACH, TGEN PROVIDED VIRTUAL INTERNSHIPS TO STUDENTS IN PROGRAMS THAT FOCUSED ON DEVELOPING PROFESSIONAL AND SCIENTIFIC SKILLS. ADDITIONALLY, TGEN PROVIDED A VIRTUAL BIOSCIENCE LEADERSHIP ACADEMY FOR STUDENTS WHERE THEY LEARNED ABOUT A VARIETY OF TOPICS WITHIN THE THEMES OF PROFESSIONAL DEVELOPMENT, LEADERSHIP, TRANSLATIONAL MEDICINE, AND HOT TOPICS IN THE BIOSCIENCES.
FORM 990, PART VI, LINE 6THE SOLE CORPORATE MEMBER OF TGEN IS CITY OF HOPE.
FORM 990, PART VI, LINE 7ATHE AFFILIATION AGREEMENT BETWEEN TGEN AND CITY OF HOPE GRANTS CITY OF HOPE THE RIGHT TO APPOINT DIRECTORS. FORM 990, PART VI, LINE 7B CERTAIN ACTIONS MAY NOT BE UNDERTAKEN WITHOUT THE PRIOR WRITTEN APPROVAL OF THE SOLE CORPORATE MEMBER, CITY OF HOPE, AS SPECIFIED IN THE GOVERNING DOCUMENTS OF TGEN, ON BEHALF OF ITSELF OR CERTAIN AFFILIATES, INCLUDING: BORROW OR LEND MONEY OR PLEDGE PROPERTY AS SECURITY; FIX COMPENSATION FOR DIRECTORS; CHANGE THE NUMBER OF VOTING DIRECTORS; ASSIGN, TRANSFER, PLEDGE, COMPROMISE OR RELEASE CERTAIN CLAIMS OR DEBTS; COMMENCE ASSIGNMENT FOR THE BENEFIT OF CREDITORS, PETITION FOR REORGANIZATION OR SIMILAR RELIEF OR ACTION; ACQUIRE, PURCHASE, DEVELOP, MATERIALLY IMPROVE, SELL, LEASE, OR MORTGAGE CORPORATE REAL ESTATE; MERGE, DISSOLVE OR SELL ALL OR SUBSTANTIALLY ALL ASSETS; ADOPT BUDGETS, STRATEGIC PLANS OR MATERIAL CHANGES TO OPERATIONS; FORM AFFILIATES OR MAKE BUSINESS INVESTMENTS; ADOPT, REPEAL OR AMEND KEY GOVERNING DOCUMENTS; EXERCISE CERTAIN GOVERNANCE RIGHTS; INCUR LIABILITIES OR CONTRACT OTHER THAN FOR FAIR CONSIDERATION AND IN THE ORDINARY COURSE OF BUSINESS.
FORM 990, PART VI, LINE 11BTHE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM BASED ON INFORMATION PROVIDED BY THE TGEN FINANCE DEPARTMENT. THE FORM 990 IS THEN REVIEWED BY THE FINANCE DEPARTMENT, OTHER MEMBERS OF MANAGEMENT AND THE AUDIT AND COMPLIANCE COMMITTEE OF THE CITY OF HOPE. THE FORM 990 IS POSTED ON THE BOARD WEBSITE FOR BOARD REVIEW PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, LINE 12CTGEN DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE ANNUALLY TO ALL DIRECTOR LEVEL POSITIONS AND ABOVE, IN ADDITION TO ANY OFFICERS AND KEY EMPLOYEES DESIGNATED BY THE CONFLICT OF INTEREST COMMITTEE. THE QUESTIONNAIRES ARE REVIEWED BY TGEN'S FINANCE DEPARTMENT AND THE OFFICE OF RESEARCH COMPLIANCE. THOSE EMPLOYEES WITH CONFLICTS ARE SENT FOR FURTHER REVIEW TO THE CONFLICT OF INTEREST COMMITTEE TO ENSURE AN APPROPRIATE PLAN IS SET FORTH. UPDATES TO THE LIST ARE HANDLED ON AN AS-NEEDED BASIS, BASED ON CONTRACT REVIEWS AND EMPLOYEE INFORMATION.
FORM 990, PART VI, LINES 15A AND 15BTHE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE MEMBER SHALL BE THE EXECUTIVE COMPENSATION COMMITTEE OF TGEN. NOTWITHSTANDING THE FOREGOING, TGEN'S EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE WILL ACT IN AN "ADVISE AND CONSENT" CAPACITY REVIEWING THE RECOMMENDATIONS OF THE PRESIDENT AND SCIENTIFIC DIRECTOR REGARDING THE COMPENSATION OF DISQUALIFIED PERSONS CONSISTENT WITH THE MEMBER'S COMPENSATION PHILOSOPHY AND WITHIN THE COMPENSATION RANGES APPROVED AT LEAST ANNUALLY BY THE MEMBER, AND FORWARDING FINAL RECOMMENDATIONS TO THE FULL TGEN BOARD FOR APPROVAL. DISQUALIFIED PERSONS (EXCEPT FOR THE PRESIDENT AND SCIENTIFIC DIRECTOR) WILL NOT BE PRESENT FOR, OR PARTICIPATE IN, COMMITTEE DELIBERATIONS CONCERNING THEIR COMPENSATION (OTHER THAN TO ANSWER QUESTIONS). THE PRESIDENT AND SCIENTIFIC DIRECTOR WILL PARTICIPATE IN THE DELIBERATIONS CONCERNING THE COMPENSATION OF DIRECT REPORTS. DURING THE DECISION MAKING PROCESS, THE COMMITTEE WILL ADHERE TO THE EXECUTIVE COMPENSATION PHILOSOPHY OF THE MEMBER. THE COMMITTEE IS AUTHORIZED (AND PROVIDED WITH SUFFICIENT FUNDING) TO ANNUALLY ENGAGE OUTSIDE INDEPENDENT COMPENSATION AND LEGAL ADVISORS, WHEN DEEMED NECESSARY AND ADVISABLE. THE COMMITTEE WILL COMPLY WITH THE "REBUTTABLE PRESUMPTION OF REASONABLENESS" UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE WHENEVER POSSIBLE. THE COMMITTEE WILL REVIEW AND UNDERSTAND THE INTERNAL REVENUE CODE PROVISIONS DEALING WITH "EXCESS BENEFIT TRANSACTIONS CONCERNING DISQUALIFIED PERSONS' COMPENSATION." WHEN DEVELOPING A COMPENSATION PHILOSOPHY, TGEN KEPT IN MIND THE FOLLOWING FACTORS: - THE TGEN MISSION AND STRATEGY - THE TGEN CULTURE - TRENDS IN COMPENSATION IN THE EXTERNAL ENVIRONMENT - TRENDS IN RECRUITMENT OF NEW EMPLOYEES - TRENDS IN ORGANIZATIONAL EMPLOYEE TURNOVER - TGEN'S LIFE CYCLE STAGE THE COMPENSATION REVIEW PROCESS WAS LAST COMPLETED IN 2020.
FORM 990, PART VI, LINE 19TGEN'S ARTICLES OF INCORPORATION ARE AVAILABLE TO THE PUBLIC THROUGH THE ARIZONA CORPORATION COMMISSION. TGEN'S AUDITED FINANCIAL STATEMENTS AND ITS CONFLICT OF INTEREST POLICIES ARE AVAILABLE BY WRITTEN REQUEST MADE TO THE CFO AND CONFLICT OF INTEREST MANAGER, RESPECTIVELY. TGEN'S BYLAWS ARE NOT MADE AVAILABLE TO THE PUBLIC.
FORM 990 PART IX LINE 11GDESCRIPTION:CONSORTIUM/CONTRACTUAL TOTAL FEES:3760493
FORM 990 PART IX LINE 11GDESCRIPTION:OUTSIDE RESEARCH SERVICES TOTAL FEES:3026368
FORM 990 PART IX LINE 11GDESCRIPTION:CONSULTING TOTAL FEES:2402766
FORM 990 PART IX LINE 11GDESCRIPTION:TEMPORARY SERVICES TOTAL FEES:200495

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (12 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdTotal IncomeTotalIncomeAmtEnd Of Year AssetsEndOfYearAssetsAmtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1Txt
THE CENTER FOR TRANS DRUG DEVELOPMENT
445 N 5TH STREET SUITE 600PHOENIXAZ85004432047329DRUG DEVELAZ$0$0TGAM LLC
TGEN ACCELERATORS LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004753065445GENOMICSAZ$0$0TGEN
TRANSLATIONAL SYSTEMS LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004461309498ADV RESEARCHAZ$0$0TGEN
VIDIUM LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004753065445ANIMAL DIAGAZ$18,160$1,174,018TGEN
TGEN HEALTH VENTURES LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004464520712HEALTHCAREAZ$0$0TGEN
DROPWISE LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004811959403RESEARCHAZ$0$7,740TGAM LLC
ID ORIGINS LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004753065445TECH TRANSFERAZ$0$0TGAM LLC
PROFERO LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004753065445LICENSINGDE$0$0TGEN
METRICBIO LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004814455083RESEARCHDE$9,100$10,233TGEN
TGEN CLINICAL LAB LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004383922888HEALTHCAREAZ$0$0TGEN HV LLC
ASHION ANALYTICS LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004454587602HEALTHCAREAZ$24,403,041$10,797,988ASHION PMED
PRECISION MEDICINE FACILITIES LLC
445 N 5TH STREET SUITE 600PHOENIXAZ85004822560090REAL ESTATEAZ$7,169,077$48,311,512TGEN

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationInd
TGEN RESEARCH INSTITUTE FOUNDATION
445 N 5TH STREET SUITE 120PHOENIXAZ85004331092191FUNDRAISINGAZ501(c)(3)7TGENYes (true)
CITY OF HOPE
1500 EAST DUARTE ROADDUARTECA91010953435919FUNDRAISINGCA501(c)(3)7NAfalse
CITY OF HOPE NATIONAL MEDICAL CENTER
1500 EAST DUARTE ROADDUARTECA91010951683875HOSPITALCA501(c)(3)3CITY OF HOPEYes (true)
BECKMAN RESEARCH INSTITUTE
1450 EAST DUARTE ROADDUARTECA91010953432210RESEARCHCA501(c)(3)4CITY OF HOPEYes (true)
CITY OF HOPE MEDICAL FOUNDATION
1500 EAST DUARTE ROADDUARTECA91010272803222HEALTHCARECA501(c)(3)3CITY OF HOPEYes (true)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1SOUTHERN CA RADIATION ONCOLOGYBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 19067AddressLine1Txt
CityDALLASCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75381ZIPCd
FieldValueIRS element (for citing)
Primary ActivitiesMGMT SERVICESPrimaryActivitiesTxt
Legal Domicile StateCALegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1NABusinessNameLine1Txt
FieldValueIRS element (for citing)
Predominant Income TypeN/APredominantIncomeTypeTxt
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgYes (true)LoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (true)PerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (true)ReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (3 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
TGEN RESEARCH INSTITUTE FOUNDATION
c$10,593,325ACTUAL COST
TGEN RESEARCH INSTITUTE FOUNDATION
q$1,840,783ACTUAL COST
CITY OF HOPE NATIONAL MEDICAL CENTER
o$1,271,237ACTUAL COST

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.